Luminoah Raises $25M in Series B Funding
The Charlottesville medical device company closed the round led by Sandbox Clinical Ventures after receiving FDA clearance for its Luminoah Flow feeding system.
Updated on Nov. 10, 2026 in Startups
Live Poll
Would you trust a portable, connected medical device for your own tube feeding?
Luminoah, a Charlottesville, Virginia medical device company, raised $25 million in a Series B financing led by Sandbox Clinical Ventures. The round includes $20 million in new equity and $5 million in previously issued convertible notes that converted as part of the financing.
Why it matters
The funding follows FDA clearance of Luminoah Flow, the company's enteral feeding system, in April 2026. The round signals investor interest in portable tube-feeding technology that lets patients move more freely during treatment.
Luminoah's $25 million Series B combines $20 million in new equity with $5 million in previously issued convertible notes that converted into the round. The company did not disclose a valuation or the size of prior funding rounds for comparison.
The players
Luminoah
A medical device company founded in 2020 and headquartered in Charlottesville, Virginia, which develops the Luminoah Flow enteral feeding system.
Sandbox Clinical Ventures
An Austin-based venture firm that led the Luminoah Series B financing.
GV
The venture capital arm of Alphabet that participated in the Luminoah Series B round.
The details
Participants include Blue Venture Fund, GV, Sands Capital, Texas Medical Center Venture Fund, the CU Healthcare Innovation Fund, and the American Gastroenterological Association GI Opportunity Fund. Luminoah Flow pairs a pocket-sized rechargeable pump and nutrition pouches with a connected mobile app that tracks feeding activity.
Timeline
April 2026: FDA clearance granted for Luminoah Flow.
November 10, 2026: Series B financing announced.
Market Landscape
Traditional feeding pumps often require patients to carry equipment on poles, which limits mobility and independence. Luminoah's portable design positions the company against that legacy format as investors back home-based enteral nutrition technology.
Patients who rely on tube feeding could gain a portable option that lets them move through their day without carrying a pole-mounted pump. Home medical equipment suppliers and health systems are the channels through which the system will reach patients as Luminoah expands distribution.
The takeaway
Portable feeding technology is shifting enteral nutrition away from equipment that tethers patients to poles. Investors backing Luminoah show confidence that home-based, data-connected feeding systems can scale across U.S. care settings.
What happens next
Luminoah plans to bring Luminoah Flow to more home medical equipment suppliers and health systems across the U.S., expand production capacity with automation, and continue developing the Luminoah Intelligence data platform.
Further reading
Explore more Startups coverage to see how other early-stage companies are raising capital.
More information
View Luminoah open job roles on the company's careers page.
Source note: This article includes information reported by The Manila times.
Live Poll
Would you trust a portable, connected medical device for your own tube feeding?
